Literature DB >> 27988095

Toxoplasma gondii: One Organism, Multiple Models.

Edina K Szabo1, Constance A M Finney2.   

Abstract

Toxoplasma gondii is an intensely studied protozoan parasite. It is also used as a model organism to research additional clinically relevant human and veterinary parasites due to ease of in vitro culture and genetic manipulation. Recently, it has been developed as a model of inflammatory bowel disease, due to their similar pathologies. However, researchers vary widely in how they use T. gondii, which makes study comparisons and interpretation difficult. The aim of this review is to provide researchers with a tool to: (i) determine the appropriateness of the different T. gondii models to their research, (ii) interpret results from the wide range of study conditions, and (iii) consider new advances in technology which could improve or refine their experimental setup.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Toxoplasma; in vitro models; in vivo models; mouse models; parasites

Mesh:

Year:  2016        PMID: 27988095     DOI: 10.1016/j.pt.2016.11.007

Source DB:  PubMed          Journal:  Trends Parasitol        ISSN: 1471-4922


  18 in total

1.  Study on the tolerance and adaptation of rats to Angiostrongylus cantonensis infection.

Authors:  Liu Ji; Xu Yiyue; He Xujin; Zheng Minghui; Zhang Mengying; Hu Yue; Wu Yanqi; Song Langui; Zeng Xin; Lin Datao; Wan Shuo; Zheng Huanqin; Wu Zhongdao; Lv Zhiyue
Journal:  Parasitol Res       Date:  2017-05-11       Impact factor: 2.289

2.  Restriction Checkpoint Controls Bradyzoite Development in Toxoplasma gondii.

Authors:  Anatoli V Naumov; Chengqi Wang; Dale Chaput; Li-Min Ting; Carmelo A Alvarez; Thomas Keller; Ahmed Ramadan; Michael W White; Kami Kim; Elena S Suvorova
Journal:  Microbiol Spectr       Date:  2022-06-02

3.  Toxoplasma invasion delayed by TgERK7 eradication.

Authors:  Zhong-Yuan Li; Xue Liang; Hai-Ting Guo; Jie Tan; Xing-Quan Zhu; Quan Liu
Journal:  Parasitol Res       Date:  2020-09-11       Impact factor: 2.289

4.  Toxoplasma gondii: Bradyzoite Differentiation In Vitro and In Vivo.

Authors:  Joshua Mayoral; Manlio Di Cristina; Vern B Carruthers; Louis M Weiss
Journal:  Methods Mol Biol       Date:  2020

5.  Screening and Identification of the Host Proteins Interacting with Toxoplasma gondii Rhoptry Protein ROP16.

Authors:  Ming Pan; Yanqin Zhou; Yifan Wang; Longjiao Li; Yongle Song; Lun Hou; Junlong Zhao
Journal:  Front Microbiol       Date:  2017-12-04       Impact factor: 5.640

Review 6.  A Systematic Review of In vitro and In vivo Activities of Anti-Toxoplasma Drugs and Compounds (2006-2016).

Authors:  Mahbobeh Montazeri; Mehdi Sharif; Shahabeddin Sarvi; Saeed Mehrzadi; Ehsan Ahmadpour; Ahmad Daryani
Journal:  Front Microbiol       Date:  2017-01-20       Impact factor: 5.640

Review 7.  The CRISPR/Cas9 system sheds new lights on the biology of protozoan parasites.

Authors:  Maciej Grzybek; Aleksandra Golonko; Aleksandra Górska; Klaudiusz Szczepaniak; Aneta Strachecka; Anna Lass; Paweł Lisowski
Journal:  Appl Microbiol Biotechnol       Date:  2018-04-06       Impact factor: 4.813

Review 8.  The calcium-dependent protein kinase 1 from Toxoplasma gondii as target for structure-based drug design.

Authors:  Emily M Cardew; Christophe L M J Verlinde; Ehmke Pohl
Journal:  Parasitology       Date:  2017-12-01       Impact factor: 3.234

9.  Effective Amelioration of Liver Fibrosis Through Lentiviral Vector Carrying Toxoplasma gondii gra15II in Murine Model.

Authors:  Lei Liu; Mengmeng Jin; Qing Tao; Li Yu; Jian Du; Cong Wang; Qingli Luo; Tian Xing; Yuanhong Xu; Jilong Shen; Deyong Chu
Journal:  Front Immunol       Date:  2018-07-06       Impact factor: 7.561

10.  The zebrafish as a novel model for the in vivo study of Toxoplasma gondii replication and interaction with macrophages.

Authors:  Nagisa Yoshida; Marie-Charlotte Domart; Christopher J Peddie; Artur Yakimovich; Maria J Mazon-Moya; Thomas A Hawkins; Lucy Collinson; Jason Mercer; Eva-Maria Frickel; Serge Mostowy
Journal:  Dis Model Mech       Date:  2020-07-20       Impact factor: 5.758

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.